0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global ADC Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-35E13231
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global ADC Drug Market Insights Forecast to 2029
BUY CHAPTERS

Global ADC Drug Market Research Report 2025

Code: QYRE-Auto-35E13231
Report
May 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

ADC Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

ADC Drug Market

ADC Drug Market

The global market for ADC Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for ADC Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ADC Drug.
The ADC Drug market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global ADC Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ADC Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of ADC Drug Market Report

Report Metric Details
Report Name ADC Drug Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer Inc., Seagen, Roche, AstraZeneca, RemeGen Co., Ltd., Rakuten Medical, Gilead(Immunomedics), ADC Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of ADC Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of ADC Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the ADC Drug Market report?

Ans: The main players in the ADC Drug Market are Pfizer Inc., Seagen, Roche, AstraZeneca, RemeGen Co., Ltd., Rakuten Medical, Gilead(Immunomedics), ADC Therapeutics

What are the Application segmentation covered in the ADC Drug Market report?

Ans: The Applications covered in the ADC Drug Market report are Breast Cancer, Lymphoma, Leukemia, Other

What are the Type segmentation covered in the ADC Drug Market report?

Ans: The Types covered in the ADC Drug Market report are First Generation ADC Drug, Second Generation ADC Drug, Third Generation ADC Drug

Recommended Reports

Drug Therapy Markets

Diagnostics & Monitoring

Pharmaceutical Services

1 ADC Drug Market Overview
1.1 Product Definition
1.2 ADC Drug by Type
1.2.1 Global ADC Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 First Generation ADC Drug
1.2.3 Second Generation ADC Drug
1.2.4 Third Generation ADC Drug
1.3 ADC Drug by Application
1.3.1 Global ADC Drug Market Value by Application (2024 VS 2031)
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.3.4 Leukemia
1.3.5 Other
1.4 Global ADC Drug Market Size Estimates and Forecasts
1.4.1 Global ADC Drug Revenue 2020-2031
1.4.2 Global ADC Drug Sales 2020-2031
1.4.3 Global ADC Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 ADC Drug Market Competition by Manufacturers
2.1 Global ADC Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global ADC Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global ADC Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of ADC Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of ADC Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of ADC Drug, Product Type & Application
2.7 Global Key Manufacturers of ADC Drug, Date of Enter into This Industry
2.8 Global ADC Drug Market Competitive Situation and Trends
2.8.1 Global ADC Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest ADC Drug Players Market Share by Revenue
2.8.3 Global ADC Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global ADC Drug Market Scenario by Region
3.1 Global ADC Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global ADC Drug Sales by Region: 2020-2031
3.2.1 Global ADC Drug Sales by Region: 2020-2025
3.2.2 Global ADC Drug Sales by Region: 2026-2031
3.3 Global ADC Drug Revenue by Region: 2020-2031
3.3.1 Global ADC Drug Revenue by Region: 2020-2025
3.3.2 Global ADC Drug Revenue by Region: 2026-2031
3.4 North America ADC Drug Market Facts & Figures by Country
3.4.1 North America ADC Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America ADC Drug Sales by Country (2020-2031)
3.4.3 North America ADC Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe ADC Drug Market Facts & Figures by Country
3.5.1 Europe ADC Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe ADC Drug Sales by Country (2020-2031)
3.5.3 Europe ADC Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific ADC Drug Market Facts & Figures by Region
3.6.1 Asia Pacific ADC Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific ADC Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific ADC Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America ADC Drug Market Facts & Figures by Country
3.7.1 Latin America ADC Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America ADC Drug Sales by Country (2020-2031)
3.7.3 Latin America ADC Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa ADC Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa ADC Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa ADC Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa ADC Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global ADC Drug Sales by Type (2020-2031)
4.1.1 Global ADC Drug Sales by Type (2020-2025)
4.1.2 Global ADC Drug Sales by Type (2026-2031)
4.1.3 Global ADC Drug Sales Market Share by Type (2020-2031)
4.2 Global ADC Drug Revenue by Type (2020-2031)
4.2.1 Global ADC Drug Revenue by Type (2020-2025)
4.2.2 Global ADC Drug Revenue by Type (2026-2031)
4.2.3 Global ADC Drug Revenue Market Share by Type (2020-2031)
4.3 Global ADC Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global ADC Drug Sales by Application (2020-2031)
5.1.1 Global ADC Drug Sales by Application (2020-2025)
5.1.2 Global ADC Drug Sales by Application (2026-2031)
5.1.3 Global ADC Drug Sales Market Share by Application (2020-2031)
5.2 Global ADC Drug Revenue by Application (2020-2031)
5.2.1 Global ADC Drug Revenue by Application (2020-2025)
5.2.2 Global ADC Drug Revenue by Application (2026-2031)
5.2.3 Global ADC Drug Revenue Market Share by Application (2020-2031)
5.3 Global ADC Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Company Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. ADC Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Inc. ADC Drug Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 Seagen
6.2.1 Seagen Company Information
6.2.2 Seagen Description and Business Overview
6.2.3 Seagen ADC Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Seagen ADC Drug Product Portfolio
6.2.5 Seagen Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche ADC Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche ADC Drug Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Company Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca ADC Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AstraZeneca ADC Drug Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 RemeGen Co., Ltd.
6.5.1 RemeGen Co., Ltd. Company Information
6.5.2 RemeGen Co., Ltd. Description and Business Overview
6.5.3 RemeGen Co., Ltd. ADC Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 RemeGen Co., Ltd. ADC Drug Product Portfolio
6.5.5 RemeGen Co., Ltd. Recent Developments/Updates
6.6 Rakuten Medical
6.6.1 Rakuten Medical Company Information
6.6.2 Rakuten Medical Description and Business Overview
6.6.3 Rakuten Medical ADC Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Rakuten Medical ADC Drug Product Portfolio
6.6.5 Rakuten Medical Recent Developments/Updates
6.7 Gilead(Immunomedics)
6.7.1 Gilead(Immunomedics) Company Information
6.7.2 Gilead(Immunomedics) Description and Business Overview
6.7.3 Gilead(Immunomedics) ADC Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Gilead(Immunomedics) ADC Drug Product Portfolio
6.7.5 Gilead(Immunomedics) Recent Developments/Updates
6.8 ADC Therapeutics
6.8.1 ADC Therapeutics Company Information
6.8.2 ADC Therapeutics Description and Business Overview
6.8.3 ADC Therapeutics ADC Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 ADC Therapeutics ADC Drug Product Portfolio
6.8.5 ADC Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 ADC Drug Industry Chain Analysis
7.2 ADC Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 ADC Drug Production Mode & Process Analysis
7.4 ADC Drug Sales and Marketing
7.4.1 ADC Drug Sales Channels
7.4.2 ADC Drug Distributors
7.5 ADC Drug Customer Analysis
8 ADC Drug Market Dynamics
8.1 ADC Drug Industry Trends
8.2 ADC Drug Market Drivers
8.3 ADC Drug Market Challenges
8.4 ADC Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global ADC Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global ADC Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global ADC Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global ADC Drug Sales (K Bottles) of Key Manufacturers (2020-2025)
 Table 5. Global ADC Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global ADC Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global ADC Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market ADC Drug Average Price (US$/Bottle) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of ADC Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of ADC Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of ADC Drug, Product Type & Application
 Table 12. Global Key Manufacturers of ADC Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global ADC Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADC Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global ADC Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global ADC Drug Sales by Region (2020-2025) & (K Bottles)
 Table 18. Global ADC Drug Sales Market Share by Region (2020-2025)
 Table 19. Global ADC Drug Sales by Region (2026-2031) & (K Bottles)
 Table 20. Global ADC Drug Sales Market Share by Region (2026-2031)
 Table 21. Global ADC Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global ADC Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global ADC Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global ADC Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America ADC Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America ADC Drug Sales by Country (2020-2025) & (K Bottles)
 Table 27. North America ADC Drug Sales by Country (2026-2031) & (K Bottles)
 Table 28. North America ADC Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America ADC Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe ADC Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe ADC Drug Sales by Country (2020-2025) & (K Bottles)
 Table 32. Europe ADC Drug Sales by Country (2026-2031) & (K Bottles)
 Table 33. Europe ADC Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe ADC Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific ADC Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific ADC Drug Sales by Region (2020-2025) & (K Bottles)
 Table 37. Asia Pacific ADC Drug Sales by Region (2026-2031) & (K Bottles)
 Table 38. Asia Pacific ADC Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific ADC Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America ADC Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America ADC Drug Sales by Country (2020-2025) & (K Bottles)
 Table 42. Latin America ADC Drug Sales by Country (2026-2031) & (K Bottles)
 Table 43. Latin America ADC Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America ADC Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa ADC Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa ADC Drug Sales by Country (2020-2025) & (K Bottles)
 Table 47. Middle East and Africa ADC Drug Sales by Country (2026-2031) & (K Bottles)
 Table 48. Middle East and Africa ADC Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa ADC Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global ADC Drug Sales (K Bottles) by Type (2020-2025)
 Table 51. Global ADC Drug Sales (K Bottles) by Type (2026-2031)
 Table 52. Global ADC Drug Sales Market Share by Type (2020-2025)
 Table 53. Global ADC Drug Sales Market Share by Type (2026-2031)
 Table 54. Global ADC Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global ADC Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global ADC Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global ADC Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global ADC Drug Price (US$/Bottle) by Type (2020-2025)
 Table 59. Global ADC Drug Price (US$/Bottle) by Type (2026-2031)
 Table 60. Global ADC Drug Sales (K Bottles) by Application (2020-2025)
 Table 61. Global ADC Drug Sales (K Bottles) by Application (2026-2031)
 Table 62. Global ADC Drug Sales Market Share by Application (2020-2025)
 Table 63. Global ADC Drug Sales Market Share by Application (2026-2031)
 Table 64. Global ADC Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global ADC Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global ADC Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global ADC Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global ADC Drug Price (US$/Bottle) by Application (2020-2025)
 Table 69. Global ADC Drug Price (US$/Bottle) by Application (2026-2031)
 Table 70. Pfizer Inc. Company Information
 Table 71. Pfizer Inc. Description and Business Overview
 Table 72. Pfizer Inc. ADC Drug Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 73. Pfizer Inc. ADC Drug Product
 Table 74. Pfizer Inc. Recent Developments/Updates
 Table 75. Seagen Company Information
 Table 76. Seagen Description and Business Overview
 Table 77. Seagen ADC Drug Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 78. Seagen ADC Drug Product
 Table 79. Seagen Recent Developments/Updates
 Table 80. Roche Company Information
 Table 81. Roche Description and Business Overview
 Table 82. Roche ADC Drug Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 83. Roche ADC Drug Product
 Table 84. Roche Recent Developments/Updates
 Table 85. AstraZeneca Company Information
 Table 86. AstraZeneca Description and Business Overview
 Table 87. AstraZeneca ADC Drug Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 88. AstraZeneca ADC Drug Product
 Table 89. AstraZeneca Recent Developments/Updates
 Table 90. RemeGen Co., Ltd. Company Information
 Table 91. RemeGen Co., Ltd. Description and Business Overview
 Table 92. RemeGen Co., Ltd. ADC Drug Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 93. RemeGen Co., Ltd. ADC Drug Product
 Table 94. RemeGen Co., Ltd. Recent Developments/Updates
 Table 95. Rakuten Medical Company Information
 Table 96. Rakuten Medical Description and Business Overview
 Table 97. Rakuten Medical ADC Drug Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 98. Rakuten Medical ADC Drug Product
 Table 99. Rakuten Medical Recent Developments/Updates
 Table 100. Gilead(Immunomedics) Company Information
 Table 101. Gilead(Immunomedics) Description and Business Overview
 Table 102. Gilead(Immunomedics) ADC Drug Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 103. Gilead(Immunomedics) ADC Drug Product
 Table 104. Gilead(Immunomedics) Recent Developments/Updates
 Table 105. ADC Therapeutics Company Information
 Table 106. ADC Therapeutics Description and Business Overview
 Table 107. ADC Therapeutics ADC Drug Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 108. ADC Therapeutics ADC Drug Product
 Table 109. ADC Therapeutics Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. ADC Drug Distributors List
 Table 113. ADC Drug Customers List
 Table 114. ADC Drug Market Trends
 Table 115. ADC Drug Market Drivers
 Table 116. ADC Drug Market Challenges
 Table 117. ADC Drug Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of ADC Drug
 Figure 2. Global ADC Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global ADC Drug Market Share by Type: 2024 & 2031
 Figure 4. First Generation ADC Drug Product Picture
 Figure 5. Second Generation ADC Drug Product Picture
 Figure 6. Third Generation ADC Drug Product Picture
 Figure 7. Global ADC Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global ADC Drug Market Share by Application: 2024 & 2031
 Figure 9. Breast Cancer
 Figure 10. Lymphoma
 Figure 11. Leukemia
 Figure 12. Other
 Figure 13. Global ADC Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global ADC Drug Market Size (2020-2031) & (US$ Million)
 Figure 15. Global ADC Drug Sales (2020-2031) & (K Bottles)
 Figure 16. Global ADC Drug Average Price (US$/Bottle) & (2020-2031)
 Figure 17. ADC Drug Report Years Considered
 Figure 18. ADC Drug Sales Share by Manufacturers in 2024
 Figure 19. Global ADC Drug Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest ADC Drug Players: Market Share by Revenue in ADC Drug in 2024
 Figure 21. ADC Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global ADC Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America ADC Drug Sales Market Share by Country (2020-2031)
 Figure 24. North America ADC Drug Revenue Market Share by Country (2020-2031)
 Figure 25. United States ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe ADC Drug Sales Market Share by Country (2020-2031)
 Figure 28. Europe ADC Drug Revenue Market Share by Country (2020-2031)
 Figure 29. Germany ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific ADC Drug Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific ADC Drug Revenue Market Share by Region (2020-2031)
 Figure 36. China ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America ADC Drug Sales Market Share by Country (2020-2031)
 Figure 44. Latin America ADC Drug Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa ADC Drug Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa ADC Drug Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE ADC Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of ADC Drug by Type (2020-2031)
 Figure 54. Global Revenue Market Share of ADC Drug by Type (2020-2031)
 Figure 55. Global ADC Drug Price (US$/Bottle) by Type (2020-2031)
 Figure 56. Global Sales Market Share of ADC Drug by Application (2020-2031)
 Figure 57. Global Revenue Market Share of ADC Drug by Application (2020-2031)
 Figure 58. Global ADC Drug Price (US$/Bottle) by Application (2020-2031)
 Figure 59. ADC Drug Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart